Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Insulin Resistance × Breast × Clear all

Phase

Phase NA 5 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1 Breast 1

Conditions

Breast Neoplasms 240 Pain, Postoperative 13 Neoplasms 9 Neoplasm Metastasis 8 Prostatic Neoplasms 6 Pain 6 Osteoporosis 6 Triple Negative Breast Neoplasms 5 Seroma 5 Colorectal Neoplasms 5 Ovarian Neoplasms 4 Breast Diseases 4 Breast Cancer Female 4 Neutropenia 3 Mastodynia 3 Cardiotoxicity 3 Bone Diseases, Metabolic 3 Vomiting 2 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sleep Initiation and Maintenance Disorders 2 Skin Diseases 2 Obesity 2 Neurotoxicity Syndromes 2 Melanoma 2 Lymphedema 2 Lung Neoplasms 2 Locally Advanced Breast Cancer 2 Head and Neck Neoplasms 2 Fractures, Bone 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04741204 2023-07-06

METBC

Woman's

Phase 4 Withdrawn

Breast Neoplasms, Insulin Resistance, Racism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡